Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest?

Published:2016-02 Issue:1 Volume:14 Page:3-6
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Swislocki Arthur L. M.¹²,Jialal Ishwarlal¹³

Affiliation:

1. Medical Service, Department of Veterans Affairs Northern California Health Care System, Sacramento, California.

2. Department of Internal Medicine, UC Davis School of Medicine, Sacramento, California.

3. Department of Pathology and Laboratory Medicine, UC Davis School of Medicine, Sacramento, California.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/met.2015.29003.swi

Reference31 articles.

1. A Summary of Criticisms of the Findings and Conclusions of the University Group Diabetes Program (UGDP)

2. xxxv. The persistent clinical failures and fallacies of the UGDP study

3. Therapy of type 2 diabetes, cardiovascular death, and the UGDP

4. Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications

5. Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study;Metabolic Syndrome and Related Disorders;2016-10

2. Hypoglycemia and the predisposition to cardiovascular disease: Is the pro-inflammatory-pro-coagulant diathesis a plausible explanation?;Atherosclerosis;2016-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3